Stocks News

LAST PRICE
165.7900
TODAY'S CHANGE (%)
Trending Up1.3400 (0.8148%)

Bid / Lots
165.5800/ 4
Ask / Lots
166.0200/ 1
Open / Previous Close
163.1900 / 164.4500
Day Range
Low 162.7350
High 165.8200
52 Week Range
Low 93.9500
High 189.9700
Volume
110,490
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

May 15, 2024
- Krystal Biotech to Present at the American Thoracic Society 2024 International Conference, from 7:00AM ET on Wednesday May 15, 2024 by GlobeNewswire
  7:00AM ET on Wednesday May 15, 2024 by GlobeNewswire
  Companies Mentioned: KRYS
- Krystal Biotech to Present at the American Thoracic Society 2024 International Conference, from 7:00AM ET on Wednesday May 15, 2024 by Dow Jones
  7:00AM ET on Wednesday May 15, 2024 by Dow Jones
  Companies Mentioned: KRYS
  
  Krystal Biotech to Present at the American Thoracic Society 2024 International Conference
  
  PITTSBURGH, May 15, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company") (NASDAQ: KRYS), a commercial-stage biotechnology company, announced today that the Company will be presenting new preclinical data on respiratory genetic medicine candidates KB407 and KB408 at the American Thoracic Society (ATS) 2024 International Conference being held from May 17-22, 2024 in San Diego, California.
May 8, 2024
- DJ Krystal Biotech Price Target Maintained With a $200.00/Share by HC Wainwright & Co., from 11:57AM ET on Wednesday May 08, 2024 by Dow Jones
  11:57AM ET on Wednesday May 08, 2024 by Dow Jones
  Companies Mentioned: KRYS
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/KRYS/analyst-ratings
  
  (END) Dow Jones Newswires
  
  May 08, 2024 11:57 ET (15:57 GMT)
- Krystal Biotech to Present at BofA Securities 2024 Health Care Conference, from 7:00AM ET on Wednesday May 08, 2024 by GlobeNewswire
  7:00AM ET on Wednesday May 08, 2024 by GlobeNewswire
  Companies Mentioned: KRYS
- Krystal Biotech to Present at BofA Securities 2024 Health Care Conference, from 7:00AM ET on Wednesday May 08, 2024 by Dow Jones
  7:00AM ET on Wednesday May 08, 2024 by Dow Jones
  Companies Mentioned: KRYS
  
  Krystal Biotech to Present at BofA Securities 2024 Health Care Conference
  
  PITTSBURGH, May 08, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company") (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the Company will participate in the BofA Securities 2024 Health Care Conference on May 14, 2024, in Las Vegas. Krish S. Krishnan, Chairman and Chief Executive Officer, will take part in a fireside chat scheduled at 2:20 pm PT and host investor meetings throughout the day.

May 17, 2024
- Nuvalent Insider Sold Shares Worth $345,450, According to a Recent SEC Filing, from 4:48PM ET on Friday May 17, 2024 by MT Newswires
  4:48PM ET on Friday May 17, 2024 by MT Newswires
  Companies Mentioned: NUVL
- Connecting the Dots of ANKTIVA's Triangle Offense: A Deep Dive with Dr. Patrick Soon-Shiong and Dr. Ashish Kamat in a Three-Part UroToday Podcast, from 9:00AM ET on Friday May 17, 2024 by Business Wire
  9:00AM ET on Friday May 17, 2024 by Business Wire
  Companies Mentioned: IBRX
- Madrigal Pharmaceuticals Insider Sold Shares Worth $4,787,404, According to a Recent SEC Filing, from 3:08AM ET on Friday May 17, 2024 by MT Newswires
  3:08AM ET on Friday May 17, 2024 by MT Newswires
  Companies Mentioned: MDGL
May 16, 2024
- Nuvalent Gets Breakthrough Therapy Designation for Lung Cancer Treatment Candidate, from 4:23PM ET on Thursday May 16, 2024 by MT Newswires
  4:23PM ET on Thursday May 16, 2024 by MT Newswires
  Companies Mentioned: NUVL
- Nuvalent Receives U.S. FDA Breakthrough Therapy Designation for NVL-655, from 4:01PM ET on Thursday May 16, 2024 by PR Newswire
  4:01PM ET on Thursday May 16, 2024 by PR Newswire
  Companies Mentioned: NUVL
- Kuehn Law Encourages Investors of ImmunityBio, Inc. to Contact Law Firm, from 10:34AM ET on Thursday May 16, 2024 by Newsfile
  10:34AM ET on Thursday May 16, 2024 by Newsfile
  Companies Mentioned: IBRX
May 15, 2024
- Investigation Alert Baxter International, Eagle Pharmaceuticals, BioXcel Therapeutics, and ImmunityBio: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information, from 1:56PM ET on Wednesday May 15, 2024 by GlobeNewswire
  1:56PM ET on Wednesday May 15, 2024 by GlobeNewswire
  Companies Mentioned: BTAI, BAX, EGRX, IBRX
May 10, 2024
- B. Riley Cuts Madrigal Pharmaceuticals' Price Target to $200 From $270, Keeps Neutral Rating, from 8:51AM ET on Friday May 10, 2024 by MT Newswires
  8:51AM ET on Friday May 10, 2024 by MT Newswires
  Companies Mentioned: MDGL
May 9, 2024
- UBS Adjusts Price Target on Madrigal Pharmaceuticals to $411 From $410, Maintains Buy Rating, from 10:53AM ET on Thursday May 09, 2024 by MT Newswires
  10:53AM ET on Thursday May 09, 2024 by MT Newswires
  Companies Mentioned: MDGL
- Nuvalent Q1 Net Loss Widens, from 7:19AM ET on Thursday May 09, 2024 by MT Newswires
  7:19AM ET on Thursday May 09, 2024 by MT Newswires
  Companies Mentioned: NUVL

Krystal Biotech Inc
NASDAQ:KRYSUnited States

Search Criteria

May 15, 2024

Krystal Biotech to Present at the American Thoracic Society 2024 International Conference, from 7:00AM ET on Wednesday May 15, 2024 by GlobeNewswire

Krystal Biotech to Present at the American Thoracic Society 2024 International Conference, from 7:00AM ET on Wednesday May 15, 2024 by Dow Jones

May 8, 2024

DJ Krystal Biotech Price Target Maintained With a $200.00/Share by HC Wainwright & Co., from 11:57AM ET on Wednesday May 08, 2024 by Dow Jones

Krystal Biotech to Present at BofA Securities 2024 Health Care Conference, from 7:00AM ET on Wednesday May 08, 2024 by GlobeNewswire

Krystal Biotech to Present at BofA Securities 2024 Health Care Conference, from 7:00AM ET on Wednesday May 08, 2024 by Dow Jones

Peers Headlines

May 17, 2024

Nuvalent Insider Sold Shares Worth $345,450, According to a Recent SEC Filing, from 4:48PM ET on Friday May 17, 2024 by MT Newswires

Connecting the Dots of ANKTIVA's Triangle Offense: A Deep Dive with Dr. Patrick Soon-Shiong and Dr. Ashish Kamat in a Three-Part UroToday Podcast, from 9:00AM ET on Friday May 17, 2024 by Business Wire

Madrigal Pharmaceuticals Insider Sold Shares Worth $4,787,404, According to a Recent SEC Filing, from 3:08AM ET on Friday May 17, 2024 by MT Newswires

May 16, 2024

Nuvalent Gets Breakthrough Therapy Designation for Lung Cancer Treatment Candidate, from 4:23PM ET on Thursday May 16, 2024 by MT Newswires

Nuvalent Receives U.S. FDA Breakthrough Therapy Designation for NVL-655, from 4:01PM ET on Thursday May 16, 2024 by PR Newswire

Kuehn Law Encourages Investors of ImmunityBio, Inc. to Contact Law Firm, from 10:34AM ET on Thursday May 16, 2024 by Newsfile

May 15, 2024

Investigation Alert Baxter International, Eagle Pharmaceuticals, BioXcel Therapeutics, and ImmunityBio: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information, from 1:56PM ET on Wednesday May 15, 2024 by GlobeNewswire

May 10, 2024

B. Riley Cuts Madrigal Pharmaceuticals' Price Target to $200 From $270, Keeps Neutral Rating, from 8:51AM ET on Friday May 10, 2024 by MT Newswires

May 9, 2024

UBS Adjusts Price Target on Madrigal Pharmaceuticals to $411 From $410, Maintains Buy Rating, from 10:53AM ET on Thursday May 09, 2024 by MT Newswires

Nuvalent Q1 Net Loss Widens, from 7:19AM ET on Thursday May 09, 2024 by MT Newswires